LOSS OF BAP1 CONFERS RESISTANCE TO FERROPTOSIS AND PROMOTES CHOLANGIOCARCINOMA DEVELOPMENT

被引：0
|
作者：
Classon, Peyton [1 ]
Jaramillo, Sophia [1 ]
Carlson, Danielle [1 ]
Yan, Irene [2 ]
Ilyas, Sumera [1 ]
Smoot, Rory [1 ]
Gores, Gregory [1 ]
Patel, Tushar
Povero, Davide [1 ]
机构：
[1] Mayo Clin Rochester, Rochester, MN USA
[2] Mayo Clin Florida, Jacksonville, FL USA
来源：
HEPATOLOGY | 2024年 / 80卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1830
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Absence of Nuclear BAP1 Protein Expression Is Highly Sensitive for Loss-of-Function BAP1 Genomic Alterations in Malignant Mesothelioma
    Pal, Prodipto
    Dong, Fei
    Vivero, Manna
    MODERN PATHOLOGY, 2016, 29 : 478A - 478A
  • [42] Radiogenomics of Intrahepatic Cholangiocarcinoma: Correlation of Imaging Features With BAP1 and FGFR Molecular Subtypes
    Cox, Veronica
    Javle, Milind
    Sun, Jia
    Kang, Hyunseon
    JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY, 2024, 48 (06) : 868 - 874
  • [43] Immunohistochemical detection of MTAP and BAP1 protein loss for mesothelioma diagnosis: Comparison with 9p21 FISH and BAP1 immunohistochemistry
    Hida, Tomoyuki
    Hamasaki, Makoto
    Matsumoto, Shinji
    Sato, Ayuko
    Tsujimura, Tohru
    Kawahara, Kunimitsu
    Iwasaki, Akinori
    Okamoto, Tatsuro
    Oda, Yoshinao
    Honda, Hiroshi
    Nabeshima, Kazuki
    LUNG CANCER, 2017, 104 : 98 - 105
  • [44] BAP1 loss defines a new class of renal cell carcinoma
    Samuel Peña-Llopis
    Silvia Vega-Rubín-de-Celis
    Arnold Liao
    Nan Leng
    Andrea Pavía-Jiménez
    Shanshan Wang
    Toshinari Yamasaki
    Leah Zhrebker
    Sharanya Sivanand
    Patrick Spence
    Lisa Kinch
    Tina Hambuch
    Suneer Jain
    Yair Lotan
    Vitaly Margulis
    Arthur I Sagalowsky
    Pia Banerji Summerour
    Wareef Kabbani
    S W Wendy Wong
    Nick Grishin
    Marc Laurent
    Xian-Jin Xie
    Christian D Haudenschild
    Mark T Ross
    David R Bentley
    Payal Kapur
    James Brugarolas
    Nature Genetics, 2012, 44 : 751 - 759
  • [45] BAP1 loss in malignant mesothelioma: distribution according the histological subtype
    Martin Lopez, J.
    Martin Acosta, P.
    Salas Anton, C.
    VIRCHOWS ARCHIV, 2020, 477 : S121 - S122
  • [46] ACSL3 is an unfavorable prognostic marker in cholangiocarcinoma patients and confers ferroptosis resistance in cholangiocarcinoma cells
    Sae-Fung, Apiwit
    Vinayavekhin, Nawaporn
    Fadeel, Bengt
    Jitkaew, Siriporn
    NPJ PRECISION ONCOLOGY, 2024, 8 (01)
  • [47] Loss of BAP1 in Pheochromocytomas and Paragangliomas Seems Unrelated to Genetic Mutations
    Maffeis, Valeria
    Cappellesso, Rocco
    Nicole, Lorenzo
    Guzzardo, Vincenza
    Menin, Chiara
    Elefanti, Lisa
    Schiavi, Francesca
    Guido, Maria
    Fassina, Ambrogio
    ENDOCRINE PATHOLOGY, 2019, 30 (04) : 276 - 284
  • [48] Loss of BAP1 Expression Occurs Rarely to Never in Colorectal Adenocarcinoma
    Chui, Jeanie
    Verdonk, Brandon
    Gill, Anthony J.
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2018, 26 (09) : e91 - e92
  • [49] Loss of BAP1 in Pheochromocytomas and Paragangliomas Seems Unrelated to Genetic Mutations
    Valeria Maffeis
    Rocco Cappellesso
    Lorenzo Nicolè
    Vincenza Guzzardo
    Chiara Menin
    Lisa Elefanti
    Francesca Schiavi
    Maria Guido
    Ambrogio Fassina
    Endocrine Pathology, 2019, 30 : 276 - 284
  • [50] Loss of BAP1 Expression Is Very Rare in Pancreatic Ductal Adenocarcinoma
    Tayao, Michael
    Andrici, Juliana
    Farzin, Mahtab
    Clarkson, Adele
    Sioson, Loretta
    Watson, Nicole
    Chua, Terence C.
    Sztynda, Tamara
    Samra, Jaswinder S.
    Gill, Anthony J.
    PLOS ONE, 2016, 11 (03):
12345